Severe Combined Immunodeficiency Due to IL-7Ralpha Deficiency
Immunology·MeSH: Brown-Vialetto-Van Laere syndrome
Prevalence
0.5 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Severe Combined Immunodeficiency Due to IL-7Ralpha Deficiency?
There are 1 clinical trial targeting Severe Combined Immunodeficiency Due to IL-7Ralpha Deficiency tracked by BioSniper.
What is the prevalence of Severe Combined Immunodeficiency Due to IL-7Ralpha Deficiency?
The estimated prevalence of Severe Combined Immunodeficiency Due to IL-7Ralpha Deficiency is approximately 0.5 per 100,000 population.
Deep-dive into Severe Combined Immunodeficiency Due to IL-7Ralpha Deficiency
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis